Yüklüyor......

Population Pharmacokinetic Analysis for Daclatasvir and Asunaprevir in Japanese Subjects With Chronic Hepatitis C Virus Infection

Daclatasvir is a nonstructural protein 5A replication complex inhibitor, and asunaprevir is a nonstructural protein 3 protease inhibitor for hepatitis C virus (HCV). In 2014, the combination therapy of daclatasvir and asunaprevir received the first global approval in Japan as the first nonribavirin,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Pharmacol
Asıl Yazarlar: Osawa, Mayu, Ueno, Takayo, Ishikawa, Hiroki, Imai, Yasuhiko, Garimella, Tushar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6174986/
https://ncbi.nlm.nih.gov/pubmed/30063254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1274
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!